Model
Edge
Revance Therapeutics Inc.
0001848717
Filing Type
144
Filing Date
6/14/2023
Updated
6/15/23, 2:30 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities